Clinical Trials Browser

Canagliflozin × Clear all

NCT05090358 2025-10-27

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms

NCT07076823 2025-07-22

Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer

Phase 1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06256289 2024-02-13

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Phase 4 Unknown

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

NCT05903703 2023-06-15

Canagliflozin With Gemcitabine in Pancreatic Carcinoma

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04700839 2022-09-10

PCOS

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome

NCT04073680 2020-05-21

A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Endometrial Neoplasms